Securities
Mar. 25, 2026
Judge bars settlement evidence ahead of Vaxart securities trial
A federal judge excluded settlement evidence in a securities case against remaining defendants, raising questions about how jurors will apportion liability without referencing parties who already resolved claims.
How can a jury apportion liability when the parties can't mention that several defendants have already settled?
Ahead of a trial with the remaining defendants, U.S. District Judge Vince G. Chhabria granted plaintiffs' motion this month to exclude evidence of their settlement with Vaxart, a biotech company they allege lied about receiving federal government funds during the Operation Warp Speed effort to develop a COVID-19 vaccine in 2020.
Vaxart, which develops v...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In